News Releases

Year

21 Jun '22

Cortexyme Announces Preclinical Data Demonstrating Efficacy of COR803 for the Treatment of Coronavirus Infections

SOUTH SAN FRANCISCO, Calif. --(BUSINESS WIRE)--Jun. 21, 2022-- Cortexyme, Inc. (Nasdaq: CRTX), a clinical-stage biopharmaceutical company focused on advancing therapeutics for rare and degenerative diseases, today announced new preclinical data demonstrating the efficacy of the company’s 3CLpro

PDF Version

13 Jun '22

Cortexyme Appoints June Bray to its Board of Directors

SOUTH SAN FRANCISCO, Calif. --(BUSINESS WIRE)--Jun. 13, 2022-- Cortexyme, Inc. (Nasdaq: CRTX), a clinical-stage biopharmaceutical company focused on rare and degenerative diseases, today announced the appointment of June Bray , a pharmaceutical industry veteran and global drug development and

PDF Version

20 May '22

Cortexyme Appoints Dr. Philip Low to Its Board of Directors

SOUTH SAN FRANCISCO, Calif. --(BUSINESS WIRE)--May 20, 2022-- Cortexyme, Inc. (Nasdaq: CRTX), a clinical-stage biopharmaceutical company pioneering therapeutic approaches to improve the lives of patients diagnosed with degenerative diseases, today announced the appointment of Dr. Philip S.

PDF Version

20 May '22

Cortexyme Successfully Completes Acquisition of Novosteo

SOUTH SAN FRANCISCO, Calif. --(BUSINESS WIRE)--May 20, 2022-- Cortexyme, Inc. (Nasdaq: CRTX), a clinical-stage biopharmaceutical company developing therapeutic approaches to improve the lives of patients diagnosed with degenerative diseases, today announced the completion of its acquisition of

PDF Version

12 May '22

Cortexyme to Participate at 4th International Conference on Porphyromonas gingivalis and Related Species in Oral and Systemic Diseases

SOUTH SAN FRANCISCO, Calif. --(BUSINESS WIRE)--May 12, 2022-- Cortexyme, Inc. (Nasdaq: CRTX), a clinical-stage biopharmaceutical company pioneering therapeutic approaches to improve the lives of patients diagnosed with degenerative diseases, announced that the company will participate at The 4 th

PDF Version

10 May '22

Cortexyme Announces Agreement to Acquire Novosteo

Expanding pipeline with addition of targeted therapeutics to treat rare skeletal diseases, bone cancer and injury Strengthening leadership team with appointment of Novosteo executives Dr. Dirk Thye as CEO and Dr. Karen Smith as CMO of combined company Planning corporate name change to Quince

PDF Version

21 Mar '22

Cortexyme Provides New GAIN Trial Data at AD/PD 2022 Demonstrating Potential Benefit of Lysine Gingipain Inhibition in Mild to Moderate Alzheimer’s Population

Target engagement and biomarker data expands understanding of the role of P. gingivalis and the potential benefit of lysine gingipain inhibition Biomarker data and correlations to clinical outcomes consistent with the gingipain hypothesis SOUTH SAN FRANCISCO, Calif. --(BUSINESS WIRE)--Mar.

PDF Version

15 Mar '22

Cortexyme Appoints Marwan Sabbagh, MD, to its Board of Directors

SOUTH SAN FRANCISCO, Calif. --(BUSINESS WIRE)--Mar. 15, 2022-- Cortexyme, Inc. (Nasdaq: CRTX), a clinical-stage biopharmaceutical company pioneering upstream therapeutic approaches to improve the lives of patients diagnosed with degenerative diseases, today announced the appointment of Marwan Noel

PDF Version

14 Mar '22

Cortexyme to Present New GAIN Trial Data at AD/PD 2022

New data expands evidence base of role of P. gingivalis in Alzheimer’s disease Discussion to include new biomarker results and correlations between biomarkers and clinical outcomes SOUTH SAN FRANCISCO, Calif. --(BUSINESS WIRE)--Mar. 14, 2022-- Cortexyme, Inc.

PDF Version

09 Mar '22

Cortexyme Announces Preclinical Data Highlighting Potential Therapeutic Benefits of Atuzaginstat for the Treatment of High-Risk Oral Potentially Malignant Disorders

First-in-class lysine gingipain inhibitor, atuzaginstat, has the potential to reduce the malignant progression of oral potentially malignant disorders (OPMD) In vitro study results demonstrate that PD-L1 is induced by P. gingivalis and can be blocked by atuzaginstat Atuzaginstat ready to begin a

PDF Version

Pagination

Current page 1
Page 2
Next page
Last page

Displaying 1 - 10 of 14